Listar por autor "Roldán Cardenete, María José"
Mostrando ítems 1-3 de 3
-
Anticlusterin treatment of breast cancer cells increases the sensitivities of chemotherapy and tamoxifen and counteracts the inhibitory action of dexamethasone on chemotherapy-induced cytotoxicity
Redondo-Bautista, Maximino
; Téllez-Santana, Teresa; Roldán Cardenete, María José; Serrano-Garballo, Alfonso; García Aranda, Marilina; Gleave, Martin E; Hortas Nieto, María Luisa; Morell Ocaña, Miguel[et al.] (BMC Springer Nature, 2007-12-13)
Introduction: Overexpression of the apoptosis-related protein clusterin is associated with breast cancer development and tumor progression. We describe the use of clusterin-specific antisense oligonucleotides and antibodies ... -
Detection methods predict differences in biology and survival in breast cancer patients
Redondo-Bautista, Maximino; Funez, Rafael; Medina Cano, Francisco José; Rodrigo, Isabel; Acebal-Blanco, María Mercedes; Téllez-Santana, Teresa; Roldán Cardenete, María José; Hortas Nieto, María Luisa; Bellinvia, Ana; Pereda, Teresa; Domingo, Laia; Morales-Suárez-Varela, María Manuela; Sala, Maria; Rueda-Domínguez, Antonio[et al.] (BMC Springer Nature, 2012)
Background: The aim of this study was to measure the biological characteristics involved in tumorigenesis and the progression of breast cancer in symptomatic and screen-detected carcinomas to identify possible difference ... -
Downregulation of clusterin mediates sensitivity to protein kinase inhibitors in breast cancer cells.
Redondo-Bautista, Maximino; García Aranda, Marilina; Roldán Cardenete, María José; Callejón, Gonzalo; Serrano-Garballo, Alfonso; Jimenez, Eugenio; Téllez-Santana, Teresa[et al.] (Lipincott, 2015)
The efficacy of protein kinase inhibitors (PKIs) has been shown in clinical assays for cancer, but as isolated agents, they only have a modest effect. One of the most important characteristics of mitogen-activated PKIs is ...